Delivery Order 36F79723D0171-75A50323F80027

Award Date 9/26/23
Potential Completion Date 9/29/26
Potential Value $84M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), has awarded a $13,675,055 firm fixed price definitive contract to Partner Therapeutics, Inc., a biopharmaceutical company based in Lexington, Massachusetts. The objective of this contract is to confirm the safety of LEUKINE in sepsis patients, inform optimal LEUKINE dosing, explore LEUKINE efficacy, and advance the development of Monocyte Human Leukocyte Antigen-DR...
This federal contract award, valued at $330,136,246.14, was granted by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to 4J Therapeutics Inc., a self-certified small disadvantaged business. The contract's objective is to demonstrate the versatility and efficacy of 4J Therapeutics' programmable antiviral technology platform by assembling a preclinical package for LNA14, performing a Phase 1a...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a time and materials delivery order contract worth $4,191,206.00 to Leidos, Inc. The contract, part of the Public Health and Social Services Emergency Fund (PHSSEF) Program Support Services Indefinite Delivery/Indefinite Quantity (PSSI IDIQ) contract vehicle, is for various professional support services to HHS. The contract is not set aside for a specific business size or...
This is a $413,697.84 Cost Plus Fixed Fee delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Leidos, Inc. The contract is under the Medical Product Research and Development indefinite delivery vehicle (IDV) and is for a Repeat Dose Toxicity Study. Leidos has subcontracted a portion of the work to SNBL U.S.A., LTD. The contract does not have a set-aside designation. This award supports MEDCOM's medical research programs, which encompass efforts related to traumatic brain...
This is a $348,666.65 delivery order awarded by the Medical Command (MEDCOM) of the U.S. Army to Leidos, Inc. for scientific and administrative support services. The contract is a time and materials arrangement with an ultimate completion date of October 30, 2016. Leidos will provide these services through its Leidos Services Operating Segment, which also does business as SAIC. The contract is not designated as a set-aside. This award positions Leidos as a key partner supporting critical medical...
This is a task order award under a federal contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $2,910,502 cost-plus-fixed-fee contract was awarded to Leidos, Inc., a global technology and engineering company, to provide preclinical services for the development of biopharmaceutical products targeting infectious diseases. The contract has a completion date of September 19, 2021 and was awarded on...
This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Pfizer Inc. for $2,151,230.00 to procure pharmaceuticals to replenish expired product. The order has an ultimate completion date of September 29, 2025 and was awarded on September 30, 2024. This delivery order is not associated with a set-aside program. Pfizer, a large pharmaceutical manufacturer, is the prime contractor and has provided pharmaceuticals,...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the prime contractor Leidos, Inc. The contract provides $204,322 in funding for administrative management and technical support activities for the development of biopharmaceutical products for infectious diseases, continuing a multi-year effort. Leidos, operating through its Leidos Services Operating Segment...
This federal contract award is for the delivery of Tenecteplase injection kits to the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the U.S. Department of Defense. The $5,209.09 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies to provide a wide range of medical supplies and pharmaceuticals. This delivery order contract has no...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, with a ceiling value of $13,591.31. The order is a firm fixed-price...
  • 36F79723D0171
    Federal Supply Schedule
  • 36F79723D0171-75A50323F80027
    Delivery Order

This is a $83,515,143.92 firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Partner Therapeutics, Inc., a for-profit biopharmaceutical company in Lexington, Massachusetts. The contract is for the supply of LEUKINE 250MCG VIL INJ (5PKG), a critical medical countermeasure. This delivery order is part of Partner Therapeutics' broader contract vehicle work with ASPR, including a $13.7 million award to confirm the safety and efficacy of LEUKINE in sepsis patients and a $748,039 contract to repurpose FX06 as a host-directed therapy for Sudan Virus Disease. The company also holds a Federal Supply Schedule contract with the Department of Veterans Affairs and an Other Transaction Agreement with the U.S. Army's Joint PEO Chemical and Biological Defense, demonstrating its ability to provide flexible, targeted solutions across multiple federal agencies in the area of medical research, drug development, and critical pharmaceutical supply. This contract award does not have a set-aside designation.

Generated 5/17/25, 10:05 AM